Ally Bridge Group (NY) LLC Quant / Systematic

CIK: 0001822947 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $402,525 (100.0% shares, 0.0% debt)

Holdings (29)

— MEDAVAIL HOLDINGS INC 8.9%

Value ($000) $35,780 Shares 2,920,780 Est. Cost $15.05 Unrealized —

— SPDR SER TR 6.7%

Value ($000) $27,080 Shares 200,000 Est. Cost — Unrealized —

NTRA NATERA INC 6.1%

Value ($000) $24,750 Shares 218,000 Est. Cost $87.13 Unrealized +17.4%

FATE FATE THERAPEUTICS INC 5.8%

Value ($000) $23,433 Shares 270,000 Est. Cost $63.35 Unrealized +27.2%

— APELLIS PHARMACEUTICALS INC 4.7%

Value ($000) $18,960 Shares 300,000 Est. Cost — Unrealized —

— SYROS PHARMACEUTICALS INC 4.7%

Value ($000) $18,747 Shares 3,439,895 Est. Cost $9.89 Unrealized —

ARVN ARVINAS INC 4.6%

Value ($000) $18,480 Shares 240,000 Est. Cost $54.99 Unrealized +26.2%

— CEREVEL THERAPEUTICS HLDNG I 4.3%

Value ($000) $17,311 Shares 675,670 Est. Cost $16.58 Unrealized —

RGEN REPLIGEN CORP 4.1%

Value ($000) $16,469 Shares 82,500 Est. Cost $181.94 Unrealized +6.6%

NUVB NUVATION BIO INC 4.0%

Value ($000) $15,902 Shares 1,708,091 Est. Cost $11.18 Unrealized +2.0%

VRDN VIRIDIAN THERAPEUTICS INC 3.9%

Value ($000) $15,728 Shares 859,910 Est. Cost $18.39 Unrealized -6.9%

— MIRATI THERAPEUTICS INC 3.8%

Value ($000) $15,345 Shares 95,000 Est. Cost $161.53 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 3.8%

Value ($000) $15,150 Shares 1,500,000 Est. Cost $10.83 Unrealized 0.0%

NTLA INTELLIA THERAPEUTICS INC 3.7%

Value ($000) $15,078 Shares 93,127 Est. Cost $36.31 Unrealized +114.4%

— CYTEIR THERAPEUTICS INC 3.3%

Value ($000) $13,414 Shares 626,843 Est. Cost $21.40 Unrealized —

COGT COGENT BIOSCIENCES INC 3.3%

Value ($000) $13,159 Shares 1,622,591 Est. Cost $10.99 Unrealized -23.1%

— NANOSTRING TECHNOLOGIES INC 3.0%

Value ($000) $11,986 Shares 185,000 Est. Cost $64.79 Unrealized —

IDYA IDEAYA BIOSCIENCES INC 2.7%

Value ($000) $10,713 Shares 510,407 Est. Cost $20.47 Unrealized +0.4%

IOVA IOVANCE BIOTHERAPEUTICS INC 2.6%

Value ($000) $10,590 Shares 406,986 Est. Cost $39.90 Unrealized -34.9%

— ESSA PHARMA INC 2.6%

Value ($000) $10,376 Shares 363,185 Est. Cost $25.37 Unrealized —

— INVITAE CORP 2.5%

Value ($000) $10,119 Shares 300,000 Est. Cost $33.73 Unrealized —

GOSS GOSSAMER BIO INC 2.4%

Value ($000) $9,541 Shares 1,175,000 Est. Cost $8.67 Unrealized 0.0%

AVIR ATEA PHARMACEUTICALS INC 2.0%

Value ($000) $8,018 Shares 373,288 Est. Cost $32.23 Unrealized -6.8%

— BOLT BIOTHERAPEUTICS INC 1.6%

Value ($000) $6,374 Shares 412,267 Est. Cost $27.64 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 1.3%

Value ($000) $5,372 Shares 85,000 Est. Cost $42.30 Unrealized +22.0%

— ADICET BIO INC 1.1%

Value ($000) $4,373 Shares 425,000 Est. Cost $13.08 Unrealized —

SPRY SILVERBACK THERAPEUTICS INC 1.0%

Value ($000) $3,972 Shares 128,572 Est. Cost $33.40 Unrealized -4.0%

— FREELINE THERAPEUTICS HLDGS 0.8%

Value ($000) $3,274 Shares 401,747 Est. Cost $18.26 Unrealized —

MGNX MACROGENICS INC 0.8%

Value ($000) $3,031 Shares 112,839 Est. Cost $29.29 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	2,920,780	$35,780	8.9%	$15.05	—	COM	58406B103
—	SPDR SER TR	200,000	$27,080	6.7%	—	—	Put	78464A950
NTRA	NATERA INC	218,000	$24,750	6.1%	$87.13	+17.4%	COM	632307104
FATE	FATE THERAPEUTICS INC	270,000	$23,433	5.8%	$63.35	+27.2%	COM	31189P102
—	APELLIS PHARMACEUTICALS INC	300,000	$18,960	4.7%	—	—	Call	03753U906
—	SYROS PHARMACEUTICALS INC	3,439,895	$18,747	4.7%	$9.89	—	COM	87184Q107
ARVN	ARVINAS INC	240,000	$18,480	4.6%	$54.99	+26.2%	COM	04335A105
—	CEREVEL THERAPEUTICS HLDNG I	675,670	$17,311	4.3%	$16.58	—	COM	15678U128
RGEN	REPLIGEN CORP	82,500	$16,469	4.1%	$181.94	+6.6%	COM	759916109
NUVB	NUVATION BIO INC	1,708,091	$15,902	4.0%	$11.18	+2.0%	COM CL A	67080N101
VRDN	VIRIDIAN THERAPEUTICS INC	859,910	$15,728	3.9%	$18.39	-6.9%	COM	92790C104
—	MIRATI THERAPEUTICS INC	95,000	$15,345	3.8%	$161.53	—	COM	60468T105
NAUT	NAUTILUS BIOTECHNOLOGY INC	1,500,000	$15,150	3.8%	$10.83	0.0%	COM	63909J108
NTLA	INTELLIA THERAPEUTICS INC	93,127	$15,078	3.7%	$36.31	+114.4%	COM	45826J105
—	CYTEIR THERAPEUTICS INC	626,843	$13,414	3.3%	$21.40	—	COM	23284P103
COGT	COGENT BIOSCIENCES INC	1,622,591	$13,159	3.3%	$10.99	-23.1%	COM	19240Q201
—	NANOSTRING TECHNOLOGIES INC	185,000	$11,986	3.0%	$64.79	—	COM	63009R109
IDYA	IDEAYA BIOSCIENCES INC	510,407	$10,713	2.7%	$20.47	+0.4%	COM	45166A102
IOVA	IOVANCE BIOTHERAPEUTICS INC	406,986	$10,590	2.6%	$39.90	-34.9%	COM	462260100
—	ESSA PHARMA INC	363,185	$10,376	2.6%	$25.37	—	COM NEW	29668H708
—	INVITAE CORP	300,000	$10,119	2.5%	$33.73	—	COM	46185L103
GOSS	GOSSAMER BIO INC	1,175,000	$9,541	2.4%	$8.67	0.0%	COM	38341P102
AVIR	ATEA PHARMACEUTICALS INC	373,288	$8,018	2.0%	$32.23	-6.8%	COM	04683R106
—	BOLT BIOTHERAPEUTICS INC	412,267	$6,374	1.6%	$27.64	—	COM	097702104
APLS	APELLIS PHARMACEUTICALS INC	85,000	$5,372	1.3%	$42.30	+22.0%	COM	03753U106
—	ADICET BIO INC	425,000	$4,373	1.1%	$13.08	—	COM	007002108
SPRY	SILVERBACK THERAPEUTICS INC	128,572	$3,972	1.0%	$33.40	-4.0%	COM	82835W108
—	FREELINE THERAPEUTICS HLDGS	401,747	$3,274	0.8%	$18.26	—	SPONSORED ADS	35655L107
MGNX	MACROGENICS INC	112,839	$3,031	0.8%	$29.29	0.0%	COM	556099109